Interested to Buy Any Domain ? << Click Here >> for more details...
1.Which drugs are suitable for extended-release formulations?
2.Criteria for selection of drugs for sustained release formulation?
- 2 Answers
- 6476 Views
- Arges Pharma Biotech, I also Faced
- E-Mail Answers
Answer Posted / deepthi
the drug should have short half life ( less than 5 hours),extended drug release and to decrease the dosing frequency of drug.
| Is This Answer Correct ? | 5 Yes | 0 No |
Post New Answer View All Answers
if one drug is acidic in nature and the other drug is basic in nature, e.g. desloratadine is soluble in acidic environment i.e 0.1N HCL whereas Montelukast Sodium is soluble in basic environment i.e. .2% SLS. How can we choose a common media for there Dissolution?
what is difference between temporary change control and deviation
how quantitative stability is done
Dear friens,this is sreedhar i am a pharmacy post graduate and having 3 years of experience in pharma industry. I am searching job in USA. through that i want to apply H1,please sugeest me how can i search job or is there any consultancies in india help me to get job?
How do you balance the benefits and risks of Alprazolam treatment when considering its prescription for an elderly patient with multiple comorbidities?
i like to know when is drug inspector exam 2009.and plz send me da question paper, interviev questions,and other details on my mail.id. shubhg2009@gmail.com. plz
What is difference between assay and content uniformity ?
Why we use 10 tablets for the analysis of cu test?
Whhat is the justification for stability study in api missed stations through deviations and statistical analysis is required.
Why do you want to make a career in pharmaceutical?
Describe some major trends in pharmaceutical field?
Why we use potassium hydrogen pthalate for determination of calibration in Total organic carbon
why u want to join as a m.r?
A patient reports not experiencing the desired relief from their anxiety symptoms after a few weeks of Alprazolam treatment. How would you assess and adjust their treatment plan?
what is difference between usfda and mhra guidline
